This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Chevron remains a heavyweight in energy stocks with a solid dividend, but recent volatility asks for a smarter plan. ...
Amcor has quietly moved higher in recent months, offering a steady income play in a volatile market. In this guide, w...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Greg Abel just sold Berkshire Hathaway's Visa and Mastercard holdings and started a new stake in a stock Warren Buffe...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
SpaceX surged on its IPO buzz, then cooled as investors weighed the risk and reward. This guide breaks down what a 30...
As Netflix prepares for its July 16 report, a developing narrative about live channels could be a pivotal signal for ...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
A disciplined fund made million MercadoLibre bets after a 35% slide, betting on a resilient platform in LATAM. This d...
Costco and Walmart are two of the most trusted names in retail. This guide breaks down their strengths, risks, and wh...